Proto Script Pharmaceutical (Proto Script Pharmaceutical) Interest Expense : $-0.65 Mil (TTM As of Sep. 2017)

View and export this data going back to 2011. Start your Free Trial

What is Proto Script Pharmaceutical Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Proto Script Pharmaceutical's interest expense for the three months ended in Sep. 2017 was $ -0.12 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2017 was $-0.65 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Proto Script Pharmaceutical's Operating Income for the three months ended in Sep. 2017 was $ -0.09 Mil. Proto Script Pharmaceutical's Interest Expense for the three months ended in Sep. 2017 was $ -0.12 Mil. Proto Script Pharmaceutical did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Proto Script Pharmaceutical Interest Expense Historical Data

The historical data trend for Proto Script Pharmaceutical's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proto Script Pharmaceutical Interest Expense Chart

Proto Script Pharmaceutical Annual Data

Trend

May12

May13

May14

May15

May16

Interest Expense

Proto Script Pharmaceutical Quarterly Data
	Nov12	Feb13	May13	Aug13	Nov13	Feb14	May14	Aug14	Nov14	Feb15	May15	Aug15	Nov15	Feb16	May16	Sep16	Dec16	Mar17	Jun17	Sep17
Interest Expense	Get a 7-Day Free Trial															-	-	-0.41	-0.12	-0.12

Proto Script Pharmaceutical Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.65 Mil.

Proto Script Pharmaceutical (OTCPK:PSCR) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Proto Script Pharmaceutical's Interest Expense for the three months ended in Sep. 2017 was $-0.12 Mil. Its Operating Income for the three months ended in Sep. 2017 was $-0.09 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2017 was $0.00 Mil.

Proto Script Pharmaceutical's Interest Coverage for the quarter that ended in Sep. 2017 is calculated as

Proto Script Pharmaceutical did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Proto Script Pharmaceutical (Proto Script Pharmaceutical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Proto Script Pharmaceutical Corp (OTCPK:PSCR) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

9830 6th Street, Suite 103, Rancho Cucamonga, CA, USA, 91730

Website

http://www.psphomecare.com

Proto Script Pharmaceutical Corp is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. It has various contracts with state and governmental insurance providers, among others. These contracts provide the company with the right to sell and repair DME and its health care insurance contracts allow it the ability to service patients nationally. The group currently has its presence of repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California.

Proto Script Pharmaceutical (Proto Script Pharmaceutical) Headlines

No Headlines